Syed, Hareem
Nadeem, Ahmed
Gardinier, David
Weekley, Kendra
Ribakow, Dovid
Lupe, Stephen
Bhat, Shubha
Holubar, Stefan
Cohen, Benjamin L.
Article History
Accepted: 15 February 2024
First Online: 29 February 2024
Declarations
:
: The authors declare no competing interests.
: Dr. Syed has nothing to disclose. Dr. Nadeem has nothing to disclose. Dr. Gardinier has nothing to disclose. Kendra Weekley has nothing to disclose. Dovid Ribakow reports personal fees from Takeda, outside the submitted work. Dr. Lupe reports personal fees from Ayble Health, personal fees from Gastro Girl/AGA GIonDemmand, outside the submitted work. Dr. Bhat reports personal fees from AbbVie, personal fees from Pfizer, personal fees from Boehringer Ingelheim, personal fees from Pharmacosmos, personal fees from Bristol Myers Squibb, personal fees from Prometheus Laboratories, outside the submitted work. Dr. Holubar reports personal fees from Shionogi, personal fees from Takeda, grants from Crohn’s & Colitis Foundation, grants from American Society of Colon & Rectal Surgeons, outside the submitted work. Dr. Cohen reports personal fees from Abbvie, personal fees from Bristol Myers Squibb, grants and personal fees from Pfizer, personal fees from Takeda, personal fees from Lilly, personal fees from Target RWE, outside the submitted work.